PSQ Holdings Sells EveryLife for $5.5M Cash, Sharpens Fintech Focus
PSQH sits 31% above its 52-week low of $2.95 on elevated volume (5.0× avg).
Summary
PSQ Holdings agreed to sell its EveryLife diaper brand for $5.5 million in cash, providing non-dilutive capital and sharpening its focus on the core fintech business.
Key Events · M&A and Partnerships · PSQH
-
EveryLife Brand Sold for $5.5M Cash
A definitive agreement has been signed to sell the direct-to-consumer diaper and baby products brand EveryLife to FreeHold Brands, LLC for $5.5 million in cash, before transaction fees and customary adjustments.
-
Non-Dilutive Capital Infusion
The all-cash transaction provides non-dilutive capital to the balance sheet, strengthening the company's financial position without issuing equity — a critical move given the recent reverse stock split and ongoing losses.
-
Strategic Exit from Non-Core Commerce
EveryLife has been classified as discontinued operations since Q3 2025; this sale completes the divestiture of the direct-to-consumer products division, allowing management to focus exclusively on the core payments and financial infrastructure business.
-
Expected Closing by September 30, 2026
The transaction is expected to close by September 30, 2026, subject to customary closing conditions, including buyer financing and regulatory approvals.
Analysis · PSQH · Trade & Services
PSQ Holdings is selling its direct-to-consumer diaper brand EveryLife for $5.5 million in cash, a non-dilutive capital infusion that strengthens the balance sheet and completes the exit from non-core commerce. The deal, expected to close by September 30, 2026, allows management to focus exclusively on its payments and financial infrastructure platform. Given the company's recent reverse stock split to maintain NYSE listing and ongoing losses, this cash injection provides critical runway without shareholder dilution.
At the time of this filing, PSQH was trading at $3.87 on NYSE in the Trade & Services sector, with a market capitalization of approximately $13.9M. The 52-week trading range was $2.95 to $42.60. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.